Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population origins

A De Lillo, GA Pathak, A Low, F De Angelis… - Human Genomics, 2024 - Springer
Purpose Coding mutations in the Transthyretin (TTR) gene cause a hereditary form of
amyloidosis characterized by a complex genotype-phenotype correlation with limited …

[HTML][HTML] Case report and literature review of cardiac amyloidosis: a not-so-rare cause of heart failure

P Baptista, SM de Azevedo, A Alexandre, A Dias-Frias - Cureus, 2023 - ncbi.nlm.nih.gov
Restrictive cardiomyopathy secondary to cardiac amyloidosis is an underdiagnosed cause
of heart failure and it is associated with significant morbidity and mortality. The most common …

[HTML][HTML] Multimodality imaging for diagnosing transthyretin cardiac amyloidosis

FFP Manzil, T Pandey - Cureus, 2023 - ncbi.nlm.nih.gov
Amyloidosis is the result of the extracellular deposition of amyloid in various organs.
Common types are light-chain and transthyretin amyloidosis. Cardiac amyloidosis (CA) is a …

[HTML][HTML] Cardiac amyloidosis in 2023: A review of pathophysiology, diagnosis, and treatment

OK Siddiqi, DM Gopal, FL Ruberg - Heart Failure Journal of India, 2023 - journals.lww.com
Cardiac amyloidosis is caused by the extracellular, interstitial deposition of misfolded protein
deposits or amyloid fibrils that result in a restrictive cardiomyopathy with associated …

[HTML][HTML] Cardiac amyloidosis in the developing world: Disease burden, management challenges and proposed approach

S Singh, A Batta, R Tandon… - Heart Failure Journal of …, 2023 - journals.lww.com
Cardiac amyloidosis (CA) is an underdiagnosed disease with rapid progression and short
overall survival. Despite therapeutic advances, resource-limited settings including India are …